The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions

Journal of Psychosomatic Obstetrics and Gynecology

Volumn 31, Issue 1, 2010, Pages 16-23

  Wang, Kung Liahng ^a,b   Jeng, Cherng Jye ^c,d   Yang, Yuh Cheng ^a   Chen, Chi An ^e   Cheng, Wen Fang ^e   Chen, Tze Chien ^a   Mast, T Christopher ^f   Wang, Ya Chuan ^f   Hsieh, Chang Yao ^e  

^a Mackay Memorial Hospital   (Myanmar)

^b Mackay Medicine   (Macao)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

CIN; Genital warts; HPV impact profile; Human papillomavirus; Psychological impact

Indexed keywords

VIRUS DNA;

ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA DETERMINATION; DOCTOR PATIENT RELATION; EDUCATIONAL STATUS; EMOTIONALITY; FEMALE; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MARRIAGE; PAPANICOLAOU TEST; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SCORING SYSTEM; SELF CONCEPT; SEXUAL BEHAVIOR; SEXUAL HEALTH; SEXUALITY; TAIWAN; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DIAGNOSIS; VIRUS TRANSMISSION;

ADULT; ATTITUDE TO HEALTH; CONDYLOMATA ACUMINATA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; QUALITY OF LIFE; QUESTIONNAIRES; TAIWAN; VAGINAL SMEARS; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES; YOUNG ADULT;

EID: 77149128683     PISSN: 0167482X     EISSN: 17438942     Source Type: Journal    
DOI: 10.3109/01674820903564440     Document Type: Article

References (36)

1. Castellsagué X, de Sanjosé S, Aguado T, Louie KS, Bruni L, Muñoz J, Diaz M, Irwin K, Gacic M, Beauvais O, et al., editors. HPV and cervical cancer in the World. 2007 Report. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Vaccine 2007; 25(Suppl 3). Available from: www.who.int/hpvcentre/en/. Last accessed December 2009.
2. Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 2008;110:S4-S7.
3. Wang PD, Lin RS. Epidemiology of cervical cancer in Taiwan. Gynecol Oncol 1996;62:344-352.
4. Lai MY, Chou P. Effectiveness of screening for cervical cancer in Taiwan. A case-control study. Zhonghua Yi Xu Za Zhi (Taipei) 1992;49:81-85 [In Chinese].
5. Bureau of Health Promotion, Department of Health, Taiwan. Available from: crs.cph.ntu.edu.tw/uploadimages/Leading- 10.pdf via the INTERNET. Last accessed December 2009.
6. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995;87:796-802.
7. Genital HPV Infection Factsheet [internet]. Rockville (MD): Centers for Disease Control and Prevention (US); National Prevention Information Network. 2009 November 24. Available from: www.cdc.gov/std/HPV/STDFact-HPV.htm Last accessed December 2009.
8. The atypical squamous cells of undetermined significance/ low-grade squamous intraepithelial lesions triage study (ALTS) group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397-402.
9. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh- Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-1610.
10. Schlecht NF, Kulaga S, Robitaille J. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-3114.
11. Kahn JA, Chiou V, Allen JD, Goodman E, Perlman SE, Emans SJ. Beliefs about Papanicolaou smears and compliance with Papanicolaou smear follow-up in adolescents. Arch Pediatr Adolesc Med 1999;153:1046-1054.
12. Cullen J, Schwartz MD, Lawrence WF, Selby JV, Mandelblatt JS. Short-term impact of cancer prevention and screening activities on quality of life. J Clin Oncology 2004;22:943-952.
13. McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the U.K. Br J Cancer 2003;88:42-46.
14. Maissi E,MarteauTM, HankinsM,Moss S, Legood R,GrayA. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross-sectional questionnaire study. BMJ 2004;328:1293.
15. McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. Br J Obstet Gynaecol 2004;111:1437-1443.
16. Doherty IE, Richardson PH, Raju KS. The assessment of the psychological effects of an abnormal cervical smear result and subsequent medical procedures. J Pscyhosom Obstet Gynaecol 1991;12:319-324.
17. Bennetts A, Irwig L, Oldenburg B, Simpson JM, Mock P, Boyes A, Adams K, Weisberg E, Shelley J. PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal pap smear. Psychosocial Effects of Abnormal Pap Smears Questionnaire. J Clin Epidemiol 1995;48:1235-1243.
18. Ung L, Conway EL, Pirotta M, Mast C, Stein AN, Palmer D, Tan J, Fairley CK, Quinn M, Carter R, et al. The Australian women's health survey: assessing the psychosocial burden of HPV related illness and preventive interventions. Sex Health 2007;4:304-305.
19. Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK, Garland S. The psychosocial burden of HPV-related disease and screening interventions. Sex Transm Inf 2009;85:508-513.
20. Mast TC, Zhu X, Demuro-Mercon C, Cummings HW, Sings HL, Ferris DG. Development and psychometric properties of the HPV impact profile (HIP) to assess the psychosocial burden of HPV. Curr Med Res Opin 2009;25:2609-2619.
21. Bullinger M, Alonso J, Apolone G, Leplège A, Sullivan M, Wood-Dauphinee S, Gandek B, Wagner A, Aaronson N, Bech P, et al. Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51:913-923
22. Richardson PH, Doherty I, Wolfe CDA, Carman N, Chamberlain F, Holtom R, Raju KS. Evaluation of cognitive behavioural counseling for the distress associated with an abnormal cervical smear result. Br J Health Psychol 1996; 1:327-338.
23. Klug SJ, Hukelmann M, Blettner M. Knowledge about infection with human papillomavirus: a systematic review. Prev Med 2008;46:87-98.
24. Munk C, Svare EI, Poll P, Bock JE, Kjaer SK. History of genital warts in 10,838 women 20-29 years of age from the general population. Risk factors and association with Papanicolaou smear history. Sex Transm Dis 1997;24:567-572.
25. Koutsky LA, Kiviat NB. Genital human papillomavirus. In: Holmes KK, et al., editors. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999:347-350.
26. CDC Media advisory: CDC's advisory committee recommends human papillomavirus vaccination [internet]. Rockville (MD): Centers for Disease Control and Prevention (US); National Prevention Information Network. 2006 Jun 29. Available from: www.cdc.gov/media/pressrel/r060629.htm. Last accessed December 2009.
27. The FUTURE II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3 and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007;369:1861-1868.
28. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928-1943. (Pubitemid 46740303)
29. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006;24 (Suppl 3):S3/35-S41.
30. Karasz A, McKee MD, Roybal K. Women's experiences of abnormal cervical cytology: illness representations, care processes, and outcomes. Ann Fam Med 2003;1:196-202.
31. Gath DH, Hallam N, Mynors-Wallis L, Day A, Bond SA. Emotional reactions in women attending a UK colposcopy clinic. J Epidemiol Community Health 1995 Feb;49:79-83.
32. Crane LA. Social support and adherence behavior among women with abnormal Pap smears. J Cancer Educ 1996;11:164-173.
33. McDonald TW, Neutens JJ, Fischer LM, Jessee D. Impact of cervical intraepithelial neoplasia diagnosis and treatment on self-esteemand body image. Gynecol Oncol 1989;34:345-349.
34. Wilkinson C, Jones JM, McBride J. Anxiety caused by abnormal result of cervical smear test: a controlled trial. BMJ 1990;300:440.
35. Llewellyn-Thomas HA. Patients' health-care decision making: a framework for descriptive and experimental investigations. Med Decis Making 1995;15:101-106.
36. Anhang R, Goodman A, Goldie SJ. HPV Communication: Review of Existing Research and Recommendations for Patient Education. CA Cancer J Clin 2004;54:248-259.